Unlock instant, AI-driven research and patent intelligence for your innovation.

Recombinant monoclonal antibodies H7 resisting fumonisins B1

A monoclonal antibody, fumonisin technology, applied in antibacterial immunoglobulin, tissue culture, microorganism-based methods, etc., can solve problems such as deletion frameshift and termination mutation, and achieve low production cost and simple operation. Effect

Inactive Publication Date: 2013-12-04
HUAZHONG AGRI UNIV
View PDF12 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, due to the existence of a large number of non-functional antibody-encoding genes in hybridoma cells and the influence of gene recombination and other factors, directly using PCR technology to amplify recombinant antibody-encoding genes from hybridoma cells may have deletions, frameshifts, and termination mutations. Phenomenon, the assembled recombinant antibody does not necessarily maintain the activity of the original parental antibody

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Recombinant monoclonal antibodies H7 resisting fumonisins B1
  • Recombinant monoclonal antibodies H7 resisting fumonisins B1
  • Recombinant monoclonal antibodies H7 resisting fumonisins B1

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0033] Example 1: Antigen Preparation

[0034] Fumonisin FB1 (purchased from Sigma) was coupled to keyhole limpet cyanin (KLH, purchased from Sigma) using glutaraldehyde one-step coupling method (KLH-NH 2 +OHC-(CH 2 ) 3 -CHO+FB1-NH 2 → KLH-N=HC-(CH 2 ) 3 -CH=N-FB1) The FB1-KLH conjugate obtained after being used as an immune antigen, the fumonisin FB1 was coupled with bovine serum albumin (BSA, purchased from Sigma Company) (BSA-NH 2 +OHC-(CH 2 ) 3 -CHO+FB1-NH 2 →BSA-N=HC-(CH 2 ) 3 The FB1-BSA conjugate obtained after -CH=N-FB1) was used as the detection and screening antigen. The specific operation process is as follows: Weigh 1mg KLH and dissolve it in 1mL PBS (ingredients: NaCl at 137mM concentration, KCl at 2.7mM concentration, NaCl at 10mM concentration 2 HPO 4 , 1.8 mM concentration of KH 2 PO 4 , pH7.2~7.4) solution, add 0.6mg FB1, mix thoroughly, add an equal volume of 2% (v / v) concentration of glutaraldehyde solution dropwise, shake at 4°C for 1h, then a...

Embodiment 2

[0035] Example 2: Immunization of mice

[0036] The antigen FB1-KLH prepared in Example 1 was used to immunize Balb / c mice (purchased from the Experimental Animal Center of Wuhan Institute of Virology, Chinese Academy of Sciences) four times. The second immunization was carried out 4 weeks (28 days) after the first immunization, and the cycle of the last three booster immunizations was 3 weeks. The immunization was performed by multi-point subcutaneous injection on the back. For the first time, 200 μL of immune antigen (100 μg) was mixed with an equal volume of Freund’s complete adjuvant for immunization, and for the last three times, 200 μL of immune antigen was mixed with an equal volume of Freund’s incomplete adjuvant for immunization. After the third immunization, blood was collected from the tail vein on the 10th day, left standing at 37° C. for 1 hour, then centrifuged at 6000 r / min for 10 minutes, and the supernatant (antiserum) was collected for indirect ELISA to detec...

Embodiment 3

[0037] Embodiment 3: Detection of antiserum titer

[0038] The specific steps are as follows:

[0039] 1) The antigen FB1-BSA prepared in Example 1 was diluted at a volume ratio of 1:400, and 100 μL / well was coated on an ELISA plate, and left overnight at 4°C.

[0040] 2) Wash the wells of the ELISA plate three times with 200 μL PBS, add 150 μL of 1% (w / v) BSA solution, and block in a 37° C. water bath for 2 hours.

[0041] 3) Wash the wells of the ELISA plate three times with 200 μL of PBS, add 100 μL of antiserum diluted with PBS, the initial concentration of dilution is 1:1000, and bathe in water at 37° C. for 2 hours.

[0042] 4) Wash the ELISA wells 3 times with 200 μL PBST (PBS solution containing 0.1% (v / v) Tween-20) and PBS, add 100 μL of AP-labeled goat anti-mouse antibody diluted at a volume ratio of 1:5000 (purchased from Sigma Company), in a 37°C water bath for 1h.

[0043] 5) Wash the wells of the ELISA plate 3 times with 200 μL PBST and PBS respectively, add 1...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the technical field of plant immunity detection and particularly relates to hybridoma cell strains capable of secreting monoclonal antibodies resisting fumonisins B1 as well as the preparation and application of recombinant monoclonal antibodies H7 of the monoclonal antibodies. The fumonisins B1 are conjugated with the carrier proteins of KLH and BSA respectively to obtain antigens; the obtained antigens FB1-KLH are used for immunizing mice; after cell fusion, selective culture is performed on the immunized mice; hybridoma cells are screened through the FB1-BSA conjugates; the hybridoma cell strains 2C5 which can stably secret the monoclonal antibodies resisting the fumonisins B1 are obtained by subcloning. The recombinant monoclonal antibodies H7 of the hybridoma cell strains 2C5 are screened according to the antibody gene pool technology and the phage display technology. According to the invention, a large quantity of the monoclonal antibodies and the recombinant monoclonal antibodies H7 are produced and purified. The obtained monoclonal antibodies 2C5 and the recombinant monoclonal antibodies H7 can be used for the immunological detection of the fumonisins B1.

Description

technical field [0001] The invention belongs to the technical field of plant immunity detection, and specifically relates to the preparation and application of an anti-fumonisin B1 monoclonal recombinant antibody H7. The hybridoma cell line can secrete an anti-fumonisin B1 monoclonal antibody, The recombinant antibody of the monoclonal antibody is further prepared by genetic engineering technology, and the monoclonal antibody or the prepared recombinant antibody can be applied to the immunological detection of fumonisins. Background technique [0002] Fumonisins were first isolated and identified from the culture fluid of Fusarium verticillioides (Sacc.) Nirenberg in 1988. They are a kind of diester compounds composed of different polyhydric alcohols and tricarboxylic acids with similar structures. , including an aliphatic chain consisting of 20 carbons and a hydrophilic side chain connected by two ester bonds. So far, dozens of fumonisin analogues or isomers have been isol...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12N5/20C07K16/12G01N33/68C12P21/08C12R1/91
Inventor 廖玉才胡祖权李和平张静柏
Owner HUAZHONG AGRI UNIV